Kimberly Westrich: With CMS moving into evidence assessment under IRA, there is talk of CMS being perceived as a national HTA body. What are your thoughts on that?
In this ‘Patti’s People’ episode, Patti Peeples of the The Peeples Collaborative speaks with Kimberly Westrich, Chief Strategy Officer, National Pharmaceutical Council (NPC). View more Patti's People episodes here. Kimberly Westrich Chief Strategy Officer, National Pharmaceutical Council (NPC) Kimberly Westrich, MA, is the Chief Strategy Officer of the NPC, which sponsors and conducts research on health policy issues related to the development and use of innovative biopharmaceuticals to improve the health of patients. NPC’s research contributes to the body of evidence that supports discussions and decisions about patient access to treatments, appropriate use, and the value innovative treatments provide to...